L-313-2019
Agreement ID
L-313-2019
Lead IC
NICHD
Exclusivity
Exclusive
External Party
Circumvent Pharmaceuticals, Inc.
Fiscal Year
2020
Territory
Worldwide
Execution Date
Effective Date
Export Date